EUCTR2014-005610-37-GB进行中（未招募）1 期
PROgesterone Therapy for Endometrial Cancer prevention in obese women (PROTEC) - PROTEC1
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1Women seen in the Sleep Apnoea Clinic at Salford Royal Hospital
- •3Informed consent
- •4Aged 18 or over
- •5Normal up to date smear
- •6Normal endometrial sample at screening
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1)Previous hysterectomy
- •2)LNG-IUS or IUD in situ or in previous 6 months
- •3)Pregnant or breast feeding
- •4)Previous endometrial ablation
- •5)Breast cancer
- •6)Congenital/acquired uterine anomaly
- •7)Pelvic inflammatory disease, current STI or genital actinomycosis
- •8)Immunodeficiency
- •9)Progestin IUS contraindicated (coagulopathy, liver disease, migraine, raised blood pressure, arterial disease)
研究者
相似试验
已完成
2 期
Progesterone therapy for endometrial cancer prevention in obese womeTopic: Cancer, Metabolic and endocrine disordersSubtopic: Gynaecological Cancer, Metabolic and Endocrine (all Subtopics)Disease: Uterus/Endometrium, Metabolic & Endocrine (not diabetes)CancerISRCTN40940943ational Institute for Health Research40
招募中
1 期
Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials – p53abn - REDRandomized phase III trial testing maintenance olaparib versus observation after adjuvant chemoradiation for p53abn endometrial cancerPatients with a histological diagnosis of p53abn HREC, treated with curative intent, after surgery (hysterectomy and bilateral salpingooophorectomy, with or without lymphadenectomy or sentinel node biopsy), without signs of residual disease or distant metastasesCTIS2023-503886-44-00Institut Gustave Roussy150
尚未招募
3 期
Study of additional treatment after surgery in endometrial cancerCTRI/2024/08/072343eiden University Medical Center
已完成
2 期
Adjuvant Chemotherapy for Endometrial cancer Trial: A randomised phase II study of TEC, TAC and ddTC for endometrial carcinomaEndometrial carcinoma with risk factors of recurrence.JPRN-UMIN000008368Gynecologic Oncology Group of Osaka (GOGO)90
已完成
不适用
POET: Prevention Of Endometrial TumoursCancerISRCTN22037489St George's, University of London & Queen Mary and Westfield College, University of London (UK)220